2,527 research outputs found
Discovery of novel reductive elimination pathway for 10-hydroxywarfarin
Coumadin (R/S-warfarin) anticoagulant therapy is highly efficacious in preventing the formation of blood clots; however, significant inter-individual variations in response risks over or under dosing resulting in adverse bleeding events or ineffective therapy, respectively. Levels of pharmacologically active forms of the drug and metabolites depend on a diversity of metabolic pathways. Cytochromes P450 play a major role in oxidizing R- and S-warfarin to 6-, 7-, 8-, 10-, and 4\u27-hydroxywarfarin, and warfarin alcohols form through a minor metabolic pathway involving reduction at the C11 position. We hypothesized that due to structural similarities with warfarin, hydroxywarfarins undergo reduction, possibly impacting their pharmacological activity and elimination. We modeled reduction reactions and carried out experimental steady-state reactions with human liver cytosol for conversion o
The Changing Epidemiology of Malaria in Ifakara Town, Southern Tanzania.
Between 1995 and 2000 there were marked changes in the epidemiology of malaria in Ifakara, southern Tanzania. We documented these changes using parasitological and clinical data from a series of community- and hospital-based studies involving children up to the age of 5 years. There was a right shift and lowering in the age-specific parasite prevalence in the community-based cohort studies. The incidence of clinical malaria in placebo-receiving infants in additional study cohorts dropped from 0.8 in 1995 to 0.43 episodes per infant per year in 2000, an incidence rate ratio of 0.53 (95% confidence interval: 0.404, 0.70, P<0.0001). At the same time, there was an increase in the total number of malaria admissions and a marked right shift in the age pattern of these admissions (median age in 1995 1.55 years vs. 2.33 in 2000, P<0.0001). However, the burden of malaria deaths remained in infants. We discuss how these dramatic changes in the epidemiology of malaria may have arisen from the use of currently available malaria control tools. Caution is required in the interpretation of hospital-based data as it is likely to underestimate the impact of anaemia on mortality in the community, where most paediatric deaths occur. Even in low/moderate malaria transmission settings, where older children suffer most malaria episodes, targeting effective malaria control at infants may produce important reductions in infant mortality caused by malaria
Fluctuations of an evaporating black hole from back reaction of its Hawking radiation: Questioning a premise in earlier work
This paper delineates the first steps in a systematic quantitative study of
the spacetime fluctuations induced by quantum fields in an evaporating black
hole. We explain how the stochastic gravity formalism can be a useful tool for
that purpose within a low-energy effective field theory approach to quantum
gravity. As an explicit example we apply it to the study of the
spherically-symmetric sector of metric perturbations around an evaporating
black hole background geometry. For macroscopic black holes we find that those
fluctuations grow and eventually become important when considering sufficiently
long periods of time (of the order of the evaporation time), but well before
the Planckian regime is reached. In addition, the assumption of a simple
correlation between the fluctuations of the energy flux crossing the horizon
and far from it, which was made in earlier work on spherically-symmetric
induced fluctuations, is carefully analyzed and found to be invalid. Our
analysis suggests the existence of an infinite amplitude for the fluctuations
of the horizon as a three-dimensional hypersurface. We emphasize the need for
understanding and designing operational ways of probing quantum metric
fluctuations near the horizon and extracting physically meaningful information.Comment: 10 pages, REVTeX; minor changes, a few references added and a brief
discussion of their relevance included. To appear in the proceedings of the
10th Peyresq meeting. Dedicated to Rafael Sorkin on the occasion of his 60th
birthda
ROSAT observations of X-ray emission from planetary nebulae
We have searched the entire ROSAT archive for useful observations to study
X-ray emission from Galactic planetary nebulae (PNs). The search yields a
sample of 63 PNs, which we call the ROSAT PN sample. About 20-25% of this
sample show X-ray emission; these include 13 definite detections and three
possible detections (at a 2-sigma level). All X-ray sources in these PNs are
concentrated near the central stars. Only A 30, BD+30 3639, and NGC 6543 are
marginally resolved by the ROSAT instruments. Three types of X-ray spectra are
seen in PNs. Type 1 consists of only soft X-ray emission (<0.5 keV), peaks at
0.1-0.2 keV, and can be fitted by blackbody models at temperatures 1-2 10^5 K.
Type 2 consists of harder X-ray emission, peaks at >0.5 keV, and can be fitted
by thin plasma emission models at temperatures of a few 10^6 K. Type 3 is a
composite of a bright Type 1 component and a fainter Type 2 component.
Unresolved soft sources with Type 1 spectra or the soft component of Type 3
spectra are most likely photospheric emission from the hot central stars.
Absorption cross sections are large for these soft-energy photons; therefore,
only large, tenuous, evolved PNs with hot central stars and small absorption
column densities have been detected. The origin of hard X-ray emission from PNs
is uncertain. PNs with Type 2 spectra are small, dense, young nebulae with
relatively cool (<<10^5 K) central stars, while PNs with Type 3 X-ray spectra
are large, tenuous, evolved nebulae with hot central stars. The hard X-ray
luminosities are also different between these two types of PNs, indicating
perhaps different origins of their hard X-ray emission. Future Chandra and XMM
observations with high spatial and spectral resolution will help to understand
the origin of hard X-ray emission from PNs.Comment: To be published in The Astrophysical Journal Supplement Series. 21
pages, 7 figures, 5 table
Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL
ADMIRE was a multi-center, randomized-controlled, open, phase IIB superiority trial in previously untreated Chronic Lymphocytic Leukemia (CLL). Conventional frontline therapy in fit patients is fludarabine, cyclophosphamide and rituximab (FCR). Initial evidence from non-randomized Phase II trials suggested that the addition of mitoxantrone to FCR (FCM-R) improved remission rates. 215 patients were recruited to assess the primary endpoint of complete remission (CR) rates according to IWCLL criteria. Secondary endpoints were progression-free survival (PFS), overall survival (OS), overall response rate, minimal residual disease (MRD) negativity and safety. At final analysis, CR rates were 69.8% FCR vs 69.3% FCM-R [adjusted odds ratio (OR): 0.97; 95%CI: (0.53-1.79), P=0.932]. MRD-negativity rates were 59.3% FCR vs 50.5% FCM-R [adjusted OR: 0.70; 95% CI: (0.39-1.26), P=0.231]. During treatment, 60.0% (n=129) of participants received G-CSF as secondary prophylaxis for neutropenia, a lower proportion on FCR compared with FCM-R (56.1 vs 63.9%). The toxicity of both regimens was acceptable. There are no significant differences between the treatment groups for PFS and OS. The trial demonstrated that the addition of mitoxantrone to FCR did not increase the depth of response. Oral FCR was well tolerated and resulted in impressive responses in terms of CR rates and MRD negativity compared to historical series with intravenous chemotherapy
Management of cases testing positive for gonococcal infection in a community-based chlamydia screening programme
Adult non-communicable disease mortality in Africa and Asia: evidence from INDEPTH Health and Demographic Surveillance System sites.
BACKGROUND: Mortality from non-communicable diseases (NCDs) is a major global issue, as other categories of mortality have diminished and life expectancy has increased. The World Health Organization's Member States have called for a 25% reduction in premature NCD mortality by 2025, which can only be achieved by substantial reductions in risk factors and improvements in the management of chronic conditions. A high burden of NCD mortality among much older people, who have survived other hazards, is inevitable. The INDEPTH Network collects detailed individual data within defined Health and Demographic Surveillance sites. By registering deaths and carrying out verbal autopsies to determine cause of death across many such sites, using standardised methods, the Network seeks to generate population-based mortality statistics that are not otherwise available. OBJECTIVE: To describe patterns of adult NCD mortality from INDEPTH Network sites across Africa and Asia, according to the WHO 2012 verbal autopsy (VA) cause categories, with separate consideration of premature (15-64 years) and older (65+ years) NCD mortality. DESIGN: All adult deaths at INDEPTH sites are routinely registered and followed up with VA interviews. For this study, VA archives were transformed into the WHO 2012 VA standard format and processed using the InterVA-4 model to assign cause of death. Routine surveillance data also provide person-time denominators for mortality rates. RESULTS: A total of 80,726 adult (over 15 years) deaths were documented over 7,423,497 person-years of observation. NCDs were attributed as the cause for 35.6% of these deaths. Slightly less than half of adult NCD deaths occurred in the 15-64 age group. Detailed results are presented by age and sex for leading causes of NCD mortality. Per-site rates of NCD mortality were significantly correlated with rates of HIV/AIDS-related mortality. CONCLUSIONS: These findings present important evidence on the distribution of NCD mortality across a wide range of African and Asian settings. This comes against a background of global concern about the burden of NCD mortality, especially among adults aged under 70, and provides an important baseline for future work
Evaluating the impact of DREAMS on HIV incidence among adolescent girls and young women: A population-based cohort study in Kenya and South Africa
Background: Through a multisectoral approach, the DREAMS Partnership aimed to reduce HIV incidence among adolescent girls and young women (AGYW) by 40% over 2 years in high-burden districts across sub-Saharan Africa. DREAMS promotes a combination package of evidence-based interventions to reduce individual, family, partner, and community-based drivers of young women’s heightened HIV risk. We evaluated the impact of DREAMS on HIV incidence among AGYW and young men in 2 settings. // Methods and findings: We directly estimated HIV incidence rates among open population-based cohorts participating in demographic and HIV serological surveys from 2006 to 2018 annually in uMkhanyakude (KwaZulu-Natal, South Africa) and over 6 rounds from 2010 to 2019 in Gem (Siaya, Kenya). We compared HIV incidence among AGYW aged 15 to 24 years before DREAMS and up to 3 years after DREAMS implementation began in 2016. We investigated the timing of any change in HIV incidence and whether the rate of any change accelerated during DREAMS implementation. Comparable analyses were also conducted for young men (20 to 29/34 years).
In uMkhanyakude, between 5,000 and 6,000 AGYW were eligible for the serological survey each year, an average of 85% were contacted, and consent rates varied from 37% to 67%. During 26,395 person-years (py), HIV incidence was lower during DREAMS implementation (2016 to 2018) than in the previous 5-year period among 15- to 19-year-old females (4.5 new infections per 100 py as compared with 2.8; age-adjusted rate ratio (aRR) = 0.62, 95% confidence interval [CI] 0.48 to 0.82), and lower among 20- to 24-year-olds (7.1/100 py as compared with 5.8; aRR = 0.82, 95% CI 0.65 to 1.04). Declines preceded DREAMS introduction, beginning from 2012 to 2013 among the younger and 2014 for the older women, with no evidence of more rapid decline during DREAMS implementation. In Gem, between 8,515 and 11,428 AGYW were eligible each survey round, an average of 34% were contacted and offered an HIV test, and consent rates ranged from 84% to 99%. During 10,382 py, declines in HIV incidence among 15- to 19-year-olds began before DREAMS and did not change after DREAMS introduction. Among 20- to 24-year-olds in Gem, HIV incidence estimates were lower during DREAMS implementation (0.64/100 py) compared with the pre-DREAMS period (0.94/100 py), with no statistical evidence of a decline (aRR = 0.69, 95% CI 0.53 to 2.18). Among young men, declines in HIV incidence were greater than those observed among AGYW and also began prior to DREAMS investments. Study limitations include low study power in Kenya and the introduction of other interventions such as universal treatment for HIV during the study period. // Conclusions: Substantial declines in HIV incidence among AGYW were observed, but most began before DREAMS introduction and did not accelerate in the first 3 years of DREAMS implementation. Like the declines observed among young men, they are likely driven by earlier and ongoing investments in HIV testing and treatment. Longer-term implementation and evaluation are needed to assess the impact of such a complex HIV prevention intervention and to help accelerate reductions in HIV incidence among young women
A qualitative understanding of the effects of reusable sanitary pads and puberty education: Implications for future research and practice
BACKGROUND: The management of menstruation has come to the fore as a barrier to girls’ education attainment in
low income contexts. Interventions have been proposed and piloted, but the emerging nature of the field means
limited evidence is available to understand their pathways of effect.
// METHODS: This study describes and compares schoolgirls’ experiences of menstruation in rural Uganda at the
conclusion of a controlled trial of puberty education and sanitary pad provision to elucidate pathways of effect in
the interventions. Semi-structured interviews were undertaken with schoolgirls who participated in the
Menstruation and the Cycle of Poverty trial concurrent with the final set of quantitative surveys. A framework
approach and cross-case analysis were employed to describe and compare the experiences of 27 menstruating girls
across the four intervention conditions; education (n = 8), reusable sanitary pads (n = 8), education with reusable
sanitary pads (n = 6), and control (n = 5).
// RESULTS: Themes included: menstrual hygiene, soiling, irritation and infection, physical experience, knowledge of
menstruation, psychological, social and cultural factors, and support from others. Those receiving reusable pads
experienced improvements in comfort and reliability. This translated into reduced fears around garment soiling and
related school absenteeism. Other menstrual hygiene challenges of washing, drying and privacy remained
prominent. Puberty education improved girls’ confidence to discuss menstruation and prompted additional support
from teachers and peers.
// CONCLUSIONS: Findings have important implications for the development and evaluation of future interventions. Results
suggest the provision of menstrual absorbents addresses one core barrier to menstrual health, but that interventions
addressing broader needs such as privacy may improve effectiveness. Puberty education sessions should increase
attention to body awareness and include strategies to address a wider range of practical menstrual challenges, including
pain management. Interviews revealed possibilities for improving quantitative surveys in future research
- …